Clinical Trials Directory

Trials / Unknown

UnknownNCT02045160

A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

In this study, we aim to investigate the incidence of the adverse reactions, the effectiveness and the gene polymorphism associated with the plasma level of sulfamethoxazole-trimethoprim and their metabolites (including N4-acetyl-sulfamethoxazole, sulfamethoxazole hydroxylamine and sulfamethoxazole-nitroso). And we also aim to investigate the factors associated with the sulfamethoxazole-trimethoprim induced acute psychosis.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-01-24
Last updated
2014-08-04

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02045160. Inclusion in this directory is not an endorsement.

A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy (NCT02045160) · Clinical Trials Directory